CAS Investment Partners Amends Cardlytics 13D Filing
Ticker: CDLX · Form: SC 13D/A · Filed: Mar 18, 2024 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | SC 13D/A |
| Filed Date | Mar 18, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.0001, $162,767,348, $64,442,344 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 13d-amendment, shareholder-activity, sec-filing
Related Tickers: CLI
TL;DR
CAS Investment Partners updated their Cardlytics filing on 3/18/24. Watch this space.
AI Summary
CAS Investment Partners, LLC, through Clifford Sosin, has amended its Schedule 13D filing for Cardlytics, Inc. on March 18, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or dollar amounts are not detailed in this excerpt. CAS Investment Partners, LLC is based in New York, NY.
Why It Matters
This amendment signals a potential shift in the investment strategy or stake of a significant shareholder in Cardlytics, Inc., which could influence the company's stock performance.
Risk Assessment
Risk Level: medium — Amendments to 13D filings often indicate changes in a significant shareholder's intentions, which can introduce volatility.
Key Players & Entities
- CAS Investment Partners, LLC (company) — Filing entity
- Cardlytics, Inc. (company) — Subject company
- Clifford Sosin (person) — Authorized person for CAS Investment Partners, LLC
FAQ
What specific changes in beneficial ownership are reported in this Amendment No. 2 to the Schedule 13D?
This excerpt does not specify the exact changes in beneficial ownership, only that an amendment has been filed on March 18, 2024.
Who is the authorized person for CAS Investment Partners, LLC filing this amendment?
Clifford Sosin is the authorized person for CAS Investment Partners, LLC.
What is the business address of CAS Investment Partners, LLC?
The business address of CAS Investment Partners, LLC is 575 Lexington Avenue, Suite 12-101, New York, NY 10022.
What is the CUSIP number for Cardlytics, Inc. common stock?
The CUSIP number for Cardlytics, Inc. common stock is 14161W105.
On what date was this Amendment No. 2 filed?
This Amendment No. 2 was filed on March 18, 2024.
Filing Stats: 2,000 words · 8 min read · ~7 pages · Grade level 11 · Accepted 2024-03-18 19:46:57
Key Financial Figures
- $0.0001 — ame of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 14161
- $162,767,348 — owned by Sosin Master is approximately $162,767,348, including brokerage commissions. The a
- $64,442,344 — ficially owned by CSWR is approximately $64,442,344, including brokerage commissions. Item
Filing Documents
- e619380_sc13da-cardlytics.htm (SC 13D/A) — 160KB
- 0001193805-24-000389.txt ( ) — 162KB
Source and Amount of Funds or Other Consideration
Item 3. Source and Amount of Funds or Other Consideration .
is hereby
Item 3 is hereby amended and restated to read as follows: The Shares purchased by each of Sosin Master and CSWR were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 4,060,506 Shares directly beneficially owned by Sosin Master is approximately $162,767,348, including brokerage commissions. The aggregate purchase price of the 1,963,170 Shares directly beneficially owned by CSWR is approximately $64,442,344, including brokerage commissions.
Interest in Securities of the Issuer
Item 5. Interest in Securities of the Issuer . Items 5(a)-(c) are hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 44,109,102 Shares outstanding, which is the total number of Shares outstanding as of February 29, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 14, 2024. A. Sosin Master (a) As of the close of business on March 18, 2024, Sosin Master directly beneficially owned 4,060,506 Shares. Percentage: Approximately 9.2% (b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 4,060,506 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 4,060,506 (c) The transactions in the Shares by Sosin Master during the past sixty days are set forth in Schedule A and are incorporated herein by reference. B. CSWR (a) As of the close of business on March 18, 2024, CSWR directly beneficially owned 1,963,170 Shares. Percentage: Approximately 4.5% (b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 1,963,170 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 1,963,170 (c) The transactions in the Shares by CSWR during the past sixty days are set forth in Schedule A and are incorporated herein by reference. C. CAS Investment (a) As the investment manager of Sosin Master and CSWR, CAS Investment may be deemed the beneficial owner of the (i) 4,060,506 Shares owned by Sosin Master and (ii) 1,963,170 Shares owned CSWR. Percentage: Approximately 13.7% (b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 6,023,676 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 6,023,676 (c) CAS Investment has not entered into any transactions